PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.\', \'IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.\', \'Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.\', \'Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.\', \'Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA 92037, USA.\', \'Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.\', \'Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA 02139, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/scitranslmed.abi9215
?:doi
?:hasPublicationType
?:journal
  • Science translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 35133175
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.7
?:rankingScore_hIndex
  • 147
is ?:relation_isRelatedTo_publication of
?:title
  • A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all